All Articles

This article summarizes a post-hoc analysis of data from the MASTER study and the GRIFFIN study of patients with newly diagnosed multiple myeloma with high-risk cytogenetic abnormalities.

This article summarizes results from an ad hoc survey conducted to evaluate nurses’ experiences with subcutaneous isatuximab administration via an on-body delivery system.

As we reflect on the many steps forward navigation has taken in 2024, it’s crucial that we also look ahead at the opportunities for advancement in 2025, collectively and individually.

As we approach the end of 2024, and on behalf of the entire Journal of Oncology Navigation & Survivorship (JONS) team, I want to express our heartfelt gratitude for your support and invaluable contributions throughout the year.

Researchers provide insights into the mechanism and treatment landscape of 2 of the 4 primary leukemia subtypes, acute lymphoblastic leukemia and acute myelogenous leukemia.

In this final installment of a 5-part series, the authors provide tools for navigators to effectively guide patients through the clinical trial experience, with a focus on important considerations for patients exploring enrollment.

In this moving personal essay, Brittany McArn, OPN-CG, CPPN, shares the impact navigation has had on her patients with cancer.

A reflection on navigation and how the field has evolved following the landmark decision by the Centers for Medicare & Medicaid Services to establish codes to reimburse for navigation services.

An overview of guiding principles for establishing the use of billing codes for navigation services at a large academic healthcare system.

The December 2024 CATCH Is awarded to Sandra M. Morales, Oncology Patient Navigator with SHARE Cancer Support.